British Toxicology Society (BTS) Annual Congress 2026
April 28, 2026
Solihull, UK
April 28, 2026
Solihull, UK
April 19, 2026
Oxford, Mississippi, USA
The Botanical Safety Consortium (BSC) is offering a special training course titled âCultivating Safety: Toxicology 101 for Botanicals and Natural Productsâ on Sunday, April 19, 2025, from 12:00â4:00 PM CT in Oxford, Mississippi, as part of the International Conference on the Science of Botanicals (ICSB).
December 12, 2019
Virtual, Webinar
An overview presentation on RISK21 was given by Michelle Embry (HESI).
September 24, 2019 – September 25, 2019
Silver Spring, Maryland, USA
The goal of this workshop is to discuss the preclinical and translational safety assessment of engineered T-cell therapies. The workshop will focus on six topics, followed by an in-depth discussion.
June 30, 2019
Los Angeles, California, USA
After the success of the 2018 CIRM/IABS â4th Cell Therapy Conference: Manufacturing and Testing of Pluripotent Stem Cellsâ and the associated HESI CT-TRACS Tumorigenicity Workshop (Abbot et al., 2018), five organizations have come together to continue the discussion and address bottlenecks associated with the ...
June 11, 2019 – June 12, 2019
Alexandria, Virginia, USA
Register now to celebrate 30 years of HESI science! This year's program will bridge our past achievements and future plans to generate science for improved decision-making, enhanced human health and safety, and protected environments.
Agenda: Please find workshop agenda here.
Accommodations: Click here to find a list of nearby hotels. Please note that participants are responsible for their own transportation to and from the US FDA site.
Requirements: To gain building access, you must bring acceptable and valid government issued identification (ID).
Registration: Onsite registration is now closed. To attend the workshop virtually, please use the webinar link located below.
Webinar: Click here to join the webinar.
[post_title] => FDA/CBER-HESI Workshop on the Safety Assessment of Engineered T-Cell Therapies [post_excerpt] => [post_status] => publish [comment_status] => closed [ping_status] => closed [post_password] => [post_name] => fda-cber-hesi-workshop-on-the-safety-assessment-of-engineered-t-cell-therapies [to_ping] => [pinged] => [post_modified] => 2020-10-28 15:00:39 [post_modified_gmt] => 2020-10-28 15:00:39 [post_content_filtered] => [post_parent] => 0 [guid] => https://hesiglobal.org/?post_type=event&p=21355 [menu_order] => 0 [post_type] => event [post_mime_type] => [comment_count] => 0 [filter] => raw ) [4] => WP_Post Object ( [ID] => 21367 [post_author] => 2 [post_date] => 2019-06-24 13:14:22 [post_date_gmt] => 2019-06-24 18:14:22 [post_content] =>
Date: June 30, 2019
After the success of the 2018 CIRM/IABS â4th Cell Therapy Conference: Manufacturing and Testing of Pluripotent Stem Cellsâ and the associated HESI CT-TRACS tumorigenicity workshop (conference report: Abbot et al. 2018), five organizations have come together to continue the discussion and address bottlenecks associated with the manufacturing and testing of pluripotent stem cell-based therapies.
The Pluripotent Stem Cells Manufacturing Meeting 2019 (PSCM2019) will be held on 30 June 2019 at the Broad CIRM Center for Regenerative Medicine and Stem Cell Research at USC (Los Angeles, California), following the International Society for Stem Cell Research (ISSCR) 2019 Annual Meeting. For more information, please contact Lucilia Mouriès (lmouries@hesiglobal.org).
This event is co-hosted by the following organizations:
![]()
Live-streaming information for the event and related materials will be available via GAiTâs website: http://www.gait.global/expert-panels-2019/
Start date in different time zones worldwide

13.00-13.25 Opening Panel: Review of takeaways from the June 2018 CIRM/IABS PSC Manufacturing, Standards, & Controls meeting; objectives and context for this yearâs discussion.
13.30-13.55 Panel 2: Pluripotent stem cells as manufacturing cell substrates â challenges encountered and forecast
14.00-14.25 Panel 3: International standardization of human pluripotent stem cell manufacturing â rationale and review of current status
14.30-14.55 Panel 4: Defining Quality Parameters of Human Pluripotent Stem Cells as manufacturing intermediates for therapeutic development
15.00-15.25 Panel 5: Outlining a road map to cell therapy comparability
16.00-16.25 Panel 6: Towards standardized tumorigenicity testing â challenges and the way forward
16.30-16.55 Panel 7: Towards automated and closed human Pluripotent Stem Cell Manufacture
17.00-17.15 Panel 8: Financial and Logistical Challenges to human Pluripotent Stem Cell Manufacture
17.20-17.35 Panel 9: Avoiding immunorejection and engraftment failure â challenges and the way forward
17.40-18.00 Closing Panel: Organizers summarizing and highlighting upcoming events
See more on the format and recommendations for participation here.
[post_title] => Pluripotent Stem Cell Manufacturing Expert Panels 2019 [post_excerpt] => [post_status] => publish [comment_status] => closed [ping_status] => closed [post_password] => [post_name] => pluripotent-stem-cell-manufacturing-expert-panels-2019 [to_ping] => [pinged] => [post_modified] => 2020-10-28 13:46:51 [post_modified_gmt] => 2020-10-28 13:46:51 [post_content_filtered] => [post_parent] => 0 [guid] => https://hesiglobal.org/?post_type=event&p=21367 [menu_order] => 0 [post_type] => event [post_mime_type] => [comment_count] => 0 [filter] => raw ) [5] => WP_Post Object ( [ID] => 21069 [post_author] => 2 [post_date] => 2019-04-02 11:51:06 [post_date_gmt] => 2019-04-02 16:51:06 [post_content] => [post_title] => 2019 HESI Annual Meeting [post_excerpt] => [post_status] => publish [comment_status] => closed [ping_status] => closed [post_password] => [post_name] => 21069 [to_ping] => [pinged] => [post_modified] => 2019-04-02 11:51:06 [post_modified_gmt] => 2019-04-02 16:51:06 [post_content_filtered] => [post_parent] => 0 [guid] => https://hesiglobal.org/?post_type=event&p=21069 [menu_order] => 0 [post_type] => event [post_mime_type] => [comment_count] => 0 [filter] => raw ) ) [post_count] => 6 [current_post] => -1 [before_loop] => [in_the_loop] => [post] => WP_Post Object ( [ID] => 30518 [post_author] => 16 [post_date] => 2026-01-16 14:31:37 [post_date_gmt] => 2026-01-16 14:31:37 [post_content] => [post_title] => British Toxicology Society (BTS) Annual Congress 2026 [post_excerpt] => [post_status] => publish [comment_status] => closed [ping_status] => closed [post_password] => [post_name] => british-toxicology-society-bts-annual-congress-2026 [to_ping] => [pinged] => [post_modified] => 2026-02-13 14:59:45 [post_modified_gmt] => 2026-02-13 14:59:45 [post_content_filtered] => [post_parent] => 0 [guid] => https://hesiglobal.org/?post_type=event&p=30518 [menu_order] => 0 [post_type] => event [post_mime_type] => [comment_count] => 0 [filter] => raw ) [comment_count] => 0 [current_comment] => -1 [found_posts] => 174 [max_num_pages] => 29 [max_num_comment_pages] => 0 [is_single] => [is_preview] => [is_page] => [is_archive] => [is_date] => [is_year] => [is_month] => [is_day] => [is_time] => [is_author] => [is_category] => [is_tag] => [is_tax] => [is_search] => [is_feed] => [is_comment_feed] => [is_trackback] => [is_home] => 1 [is_privacy_policy] => [is_404] => [is_embed] => [is_paged] => 1 [is_admin] => [is_attachment] => [is_singular] => [is_robots] => [is_favicon] => [is_posts_page] => [is_post_type_archive] => [query_vars_hash:WP_Query:private] => e2f668c04d00d14703d472603bdb2781 [query_vars_changed:WP_Query:private] => [thumbnails_cached] => [allow_query_attachment_by_filename:protected] => [stopwords:WP_Query:private] => [compat_fields:WP_Query:private] => Array ( [0] => query_vars_hash [1] => query_vars_changed ) [compat_methods:WP_Query:private] => Array ( [0] => init_query_flags [1] => parse_tax_query ) [query_cache_key:WP_Query:private] => wp_query:67a1451ef61edd74b3b7a7a96349d1eb:0.04295500 1776640497 )hesi@hesiglobal.org
Phone: +1-202-659-8404
Fax: +1-202-659-8403
740 15th Street NW, Suite 600
Washington, DC 20005
Sign up for our monthly e-newsletter.